Reproducibility of cognitive endpoints in clinical trials: lessons from neurofibromatosis type 1.

Authors

Jonathan M. Payne
Stephen J C Hearps
Karin S. Walsh, George Washington University
Iris Paltin
Belinda Barton
Nicole J. Ullrich
Kristina M. Haebich
David Coghill
Gerard A. Gioia, George Washington University
Alan Cantor
Gary Cutter
James H. Tonsgard
David Viskochil
Celiane Rey-Casserly
Elizabeth K. Schorry
Joseph D. Ackerson
Laura Klesse
Michael J. Fisher
David H. Gutmann
Tena Rosser
Roger J. Packer, George Washington University
Bruce Korf
Maria T. Acosta, George Washington University
Kathryn N. North
NF Clinical Trials Consortium

Document Type

Journal Article

Publication Date

12-3-2019

Journal

Annals of Clinical and Translational Neurology

DOI

10.1002/acn3.50952

Comments

Epub ahead of print

APA Citation

Payne, J. M., Hearps, S. J., Walsh, K. S., Paltin, I., Barton, B., Ullrich, N. J., Haebich, K. M., Coghill, D., Gioia, G. A., Cantor, A., Cutter, G., Tonsgard, J. H., Viskochil, D., Rey-Casserly, C., Schorry, E. K., Ackerson, J. D., Klesse, L., Fisher, M. J., Gutmann, D. H., Rosser, T., Packer, R. J., Korf, B., Acosta, M. T., North, K. N., & Consortium, N. T. (2019). Reproducibility of cognitive endpoints in clinical trials: lessons from neurofibromatosis type 1.. Annals of Clinical and Translational Neurology, (). http://dx.doi.org/10.1002/acn3.50952

Peer Reviewed

1

Open Access

1